A clinical prediction model for definite multiple sclerosis in patients with clinically isolated syndrome

被引：0
|
作者：
Runia, T. F. [1 ]
Jafari, N. [1 ]
Siepman, D. A. M. [1 ]
Nieboer, D. [2 ]
Steyerberg, E. [2 ]
Hintzen, R. Q. [1 ]
机构：
[1] Erasmus MC, Neurol, Rotterdam, Netherlands
[2] Erasmus MC, Biostat, Rotterdam, Netherlands
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P768
引用
收藏
页码：404 / 404
页数：1
相关论文
共 50 条
  • [41] Use of multiple biomarkers to improve the prediction of multiple sclerosis in patients with clinically isolated syndromes
    Martinelli, V.
    Dalla Costa, G.
    Messina, M. J.
    Di Maggio, G.
    Moiola, L.
    Rodegher, M.
    Colombo, B.
    Leocani, L.
    Furlan, R.
    Comi, G.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 370 - 371
  • [42] CSF Abnormalities and the Risk of Clinically Definite Multiple Sclerosis in Patients with Clinically Isolated Syndromes: A Meta-Analysis of Placebo Patients from the Interferon Beta and Glatiramer Acetate Clinically Isolated Syndrome Trials
    Riley, Claire
    Smrtka, Jennifer
    Khalid, Shahram
    Wang, Shuang
    Tullman, Mark J.
    NEUROLOGY, 2009, 72 (11) : A78 - A78
  • [43] Relevance of the study of oligoclonal bands as a prognostic factor of the conversion of clinically isolated syndrome into clinically definite multiple sclerosis in daily practice
    Dionet, Elsa
    Taithe, Frederic
    Lauxerois, Michel
    Fogli, Anne
    Clavelou, Pierre
    MULTIPLE SCLEROSIS, 2008, 14 : S119 - S119
  • [44] Higher T2 lesion volume in clinically isolated syndrome indicates higher risk of clinically definite multiple sclerosis
    Kalincik, T.
    Vaneckova, M.
    Krasensky, J.
    Seidl, Z.
    Tyblova, M.
    Volna, J.
    Havrdova, E.
    Horakova, D.
    JOURNAL OF NEUROLOGY, 2012, 259 : S49 - S49
  • [45] Treatment with glatiramer acetate delays conversion to clinically definite multiple sclerosis (CDMS) in patients with clinically isolated syndromes (CIS)
    Comi, Giancarlo
    Filippi, Massimo
    NEUROLOGY, 2008, 71 (02) : 153 - 153
  • [46] Vitamin D deficiency predicts early conversion of clinically isolated syndrome to clinically definite multiple sclerosis: A preliminary Egyptian study
    Shaheen, H.
    Sobhy, S.
    Ibrahim, L.
    Abdelaziz, H.
    Taha, M.
    Daker, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 653 - 653
  • [47] No impact of adult attachment and temperament on clinical variability in patients with clinically isolated syndrome and early multiple sclerosis
    Fazekas, Christian
    Khalil, Michael
    Enzinger, Christian
    Matzer, Franziska
    Fuchs, Siegrid
    Fazekas, Franz
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 (03) : 293 - 297
  • [48] Predicting clinical conversion to multiple sclerosis in patients with clinically isolated syndrome using machine learning techniques
    Ciccarelli, O.
    Kwok, P. P.
    Wottschel, V.
    Chard, D.
    Stromillo, M. L.
    De Stefano, N.
    Thompson, A. J.
    Miller, D. H.
    Alexander, D. H.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 30 - 31
  • [49] Clinical characteristics and predictors for development of multiple sclerosis in Chinese patients with clinically isolated syndrome: A prospective study
    Shiu, KL
    Tsoi, TH
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S246 - S246
  • [50] AMETYST - Results of an Observational Phase IV Clinical Study Evaluating the Effect of Intramuscular Interferon Beta-1a Therapy in Patients with Clinically Isolated Syndrome or Clinically Definite Multiple Sclerosis
    Stourac, P.
    Horakova, D.
    Klimova, E.
    Turcani, P.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2017, 80 (06) : 660 - 665
12345